Clinical Guides
Rheumatic Heart Disease
A clinically focused, India-adapted guide to rheumatic heart disease spanning diagnosis, secondary antibiotic prophylaxis, valve and heart-failure care, pregnancy, intervention and realistic public-sector access.
MedNext Academy | 13 min read
Rheumatic Heart Disease
A clinically focused, India-adapted guide to rheumatic heart disease spanning diagnosis, secondary antibiotic prophylaxis, valve and heart-failure care, pregnancy, intervention and realistic public-sector access.
Summary
Rheumatic heart disease (RHD) is permanent valve damage that follows one or more episodes of acute rheumatic fever (ARF), an immune-mediated complication of group A streptococcal infection. Mitral regurgitation is common early; years of inflammation and scarring can produce mitral stenosis, mixed mitral disease, aortic involvement and secondary tricuspid regurgitation. RHD is not simply a murmur and is not diagnosed by an antistreptolysin titre alone. Patients may be detected after ARF, through echocardiographic screening, or only when atrial fibrillation, embolic stroke, pulmonary hypertension, heart failure, infective endocarditis or pregnancy unmasks advanced disease.
Management links prevention and haemodynamics. Treat suspected streptococcal pharyngitis according to an evidence-based local strategy; after ARF or established RHD, long-term secondary antibiotic prophylaxis reduces recurrent fever and cumulative valve injury. Each injection or tablet therefore has disease-modifying preventive intent, whereas diuretics and rate control chiefly relieve consequences. Echocardiography defines lesions, severity and ventricular response. Severe rheumatic mitral stenosis with suitable anatomy may be treated by percutaneous mitral commissurotomy; unfavourable or multivalve disease may require repair or replacement. Anticoagulation, pregnancy planning and prosthetic-valve care require lesion-specific expertise. Genetic susceptibility exists at population level, but no routine clinical genetic test establishes RHD or replaces infection prevention. This reviewed draft has been reviewed by the MedNext Clinical Team by the MedNext Clinical Team and cannot substitute for local cardiology, obstetric or surgical protocols.
How Common Is It?
RHD remains concentrated in low- and middle-income settings and disadvantaged communities, but prevalence is difficult to compare. Auscultation detects fewer cases than echocardiographic screening; school surveys omit adults and children outside education; hospital cohorts over-represent symptomatic disease; and access to surgery changes survival. Borderline echocardiographic changes are not equivalent to clinically established valve disease. Global estimates should therefore be reported with the detection method, age group and region rather than applied mechanically to one Indian district. Women and girls are often over-represented in clinical cohorts, partly because pregnancy exposes haemodynamic consequences and because social barriers may delay care.
India has both a large absolute burden and striking geographic, socioeconomic and health-system variation. Historical reports and local surveys cannot provide one current national prevalence. Declining ARF in some urban populations coexists with persistent risk where crowding, delayed sore-throat treatment, incomplete prophylaxis and limited echocardiography remain. RHD often begins in childhood yet severe stenosis, atrial fibrillation and pulmonary hypertension appear during adolescence or adulthood after a silent interval. The burden includes missed schooling, reduced work, repeated travel for injections, anticoagulation monitoring, pregnancy risk and catastrophic out-of-pocket valve intervention. Secondary prophylaxis adherence and timely referral materially influence recurrence and progression, but observational evidence is vulnerable to access bias. A service should therefore maintain its own register: age, lesion, ARF history, prophylaxis schedule, missed doses, pregnancy potential, anticoagulation, echo surveillance and referral outcome are more actionable than a decontextualised prevalence statistic.
Risk Factors
The initiating exposure is infection with rheumatogenic group A streptococci, followed by an abnormal immune response in a susceptible host. Crowded housing, poverty, barriers to primary care, delayed recognition of sore throat or skin infection, and inconsistent antibiotic availability sustain transmission and missed prevention. School-age children have the highest ARF risk, although recurrence can occur later. A previous ARF episode is the strongest practical predictor of another; recurrent attacks add valve injury, particularly when secondary prophylaxis is interrupted. Families and communities may cluster because exposure, access and polygenic immune susceptibility are shared. There is no validated genetic panel for diagnosing RHD, forecasting an individual child’s course or screening relatives, and genetic language must not obscure the preventable infectious pathway.
Progression after RHD develops is influenced by lesion severity, repeated ARF, atrial fibrillation, pulmonary hypertension, ventricular dysfunction, pregnancy, anaemia and delayed intervention. A poorly tolerated benzathine penicillin injection, fear of allergy, migration, school or work conflict, stock-outs and lack of a patient register are adherence risks that should be addressed rather than labelled non-compliance. Prior stroke, left-atrial enlargement or spontaneous echo contrast increases thromboembolic concern. Poor dentition and invasive infection may contribute to infective endocarditis risk, but routine antibiotic prophylaxis is limited to guideline-defined high-risk cardiac situations rather than all native RHD. Pregnancy risk rises with clinically significant mitral stenosis, pulmonary hypertension, ventricular dysfunction, atrial fibrillation or a mechanical prosthesis. Environmental and service determinants are causal parts of the RHD pathway; counselling the patient without repairing continuity of care is insufficient prevention.
Diagnosis
Diagnosis separates active ARF, established structural RHD and the haemodynamic complications of a particular valve lesion. A normal auscultation does not exclude early echo-detected disease, while minor physiological regurgitation must not be overcalled.
History
Ask about exertional breathlessness, orthopnoea, oedema, haemoptysis, fatigue, palpitations, syncope, chest discomfort, fever and embolic neurological symptoms. Reconstruct previous migratory polyarthritis, carditis, chorea, erythema marginatum or subcutaneous nodules and whether Jones criteria were documented. Record sore-throat or skin-infection episodes, antibiotic treatment, secondary prophylaxis formulation, interval, missed doses and reactions. Obtain pregnancy intentions and history, anticoagulant use, bleeding, dental infection, previous commissurotomy or surgery and prosthetic-valve records.
Examination
Measure pulse rhythm, blood pressure, oxygen saturation, temperature and signs of congestion or poor perfusion. Look for atrial fibrillation, malar flush, tapping apex, opening snap and a low-pitched mid-diastolic murmur of mitral stenosis; apical pansystolic regurgitation; aortic regurgitation signs; pulmonary hypertension, right-ventricular lift, tricuspid regurgitation, hepatomegaly, ascites and oedema. During possible ARF, examine joints, skin, subcutaneous tissues, heart and neurological system, including subtle chorea.
Investigations
ECG assesses rhythm, chamber clues and conduction; chest radiography helps evaluate congestion and enlargement. Transthoracic echo defines valve morphology, commissural fusion, stenosis area and gradient, regurgitation, other valves, atrial size, ventricular function and pulmonary pressure. Transoesophageal echo is used selectively before intervention or to exclude left-atrial thrombus. In suspected ARF, inflammatory markers and evidence of preceding streptococcal infection support Jones-criteria assessment but neither proves chronic RHD alone. Blood cultures precede antibiotics when endocarditis is suspected. Test renal, liver, thyroid and haematological status according to heart failure, anticoagulation and pregnancy needs.
Differential Diagnosis
Degenerative mitral stenosis from annular calcification occurs in older patients and lacks the typical rheumatic commissural fusion; its intervention options differ. Congenital mitral lesions, cor triatriatum and left-atrial obstruction can mimic inflow stenosis. Mitral regurgitation may arise from prolapse, endocarditis, papillary-muscle ischaemia, dilated cardiomyopathy or congenital cleft rather than rheumatic leaflet and subvalvular change. A bicuspid valve, connective-tissue disease, endocarditis and aortic-root disease can explain aortic regurgitation. Functional tricuspid regurgitation commonly reflects pulmonary hypertension or right-heart dilatation and should not automatically be labelled primary rheumatic involvement.
For a febrile patient with joint pain, distinguish ARF from septic arthritis, disseminated infection, viral arthritis, post-streptococcal reactive arthritis, juvenile idiopathic arthritis, systemic lupus erythematosus and other inflammatory disease. Infective endocarditis can cause fever, new regurgitation, emboli and inflammatory markers in a patient who already has RHD; obtaining cultures before antimicrobial treatment is crucial when stable enough. Chorea has neurological, autoimmune, toxic and functional differentials. Dyspnoea in pregnancy may be physiological, anaemic, thromboembolic, hypertensive, infectious or cardiomyopathic, but significant mitral stenosis must be actively excluded when symptoms or a murmur are present. A positive antistreptolysin O result reflects recent immune exposure, varies with background titres and timing, and cannot by itself distinguish ARF, chronic RHD or an unrelated illness. The diagnostic statement should name each valve lesion and severity, rhythm, ventricular response and pulmonary pressure rather than using RHD as a complete haemodynamic description.
Management
Prevention starts upstream. Use a validated clinical or microbiological strategy for suspected group A streptococcal pharyngitis and give an effective antibiotic regimen when indicated. Patients with prior ARF or established RHD need long-term secondary prophylaxis; intramuscular benzathine benzylpenicillin is generally the most effective option, while oral alternatives are used when injection delivery is not feasible or appropriate. Duration is individualised by ARF history, residual valve disease, age, exposure risk, intervention history and specialist guidance; severe residual disease or valve surgery often warrants very prolonged or lifelong prevention. Build adherence through recall systems, reliable supply, skilled injection, pain-reduction options, education and a plan for true allergy. Valve intervention does not erase recurrence risk. Comparative evidence for some schedules, screening pathways and adherence interventions is limited or context dependent, so programmes should audit recurrence, adverse events and missed doses.
Treat consequences without mistaking symptom control for valve correction. Diuretics reduce pulmonary or systemic congestion. Control ventricular rate in atrial fibrillation; restore rhythm selectively. Use a vitamin K antagonist for rheumatic mitral stenosis with atrial fibrillation and for mechanical prosthetic valves according to target INR; direct oral anticoagulants are not a substitute in these settings. Treat systolic heart failure with guideline-directed medicines when present, recognising that severe mechanical stenosis or regurgitation may still require intervention. A pacemaker, ICD or CRT follows its conventional conduction, arrhythmic or systolic-failure indication and does not treat rheumatic valve obstruction. For clinically severe rheumatic mitral stenosis, percutaneous commissurotomy is preferred when symptoms or high-risk features justify treatment and anatomy is suitable without left-atrial thrombus or more than mild mitral regurgitation. Surgery is required for unfavourable anatomy, important regurgitation, failed procedures or multivalve disease. Heart Team review should integrate repair durability, prosthesis choice, anticoagulation, pregnancy and local follow-up.
Prescribing Information
Secondary prophylaxis must be prescribed as a programme, not an isolated injection. Confirm the indication, prior reaction, product, dose appropriate to age or weight, interval, administration site, next due date and responsible clinic. Intramuscular benzathine benzylpenicillin requires trained staff, correct deep injection technique, observation and readiness to recognise and treat anaphylaxis; vasovagal reactions and injection pain should be distinguished from true allergy. Do not automatically deny the most effective prophylaxis because of an unverified allergy label. Where specialist evaluation supports an oral alternative, explain that daily adherence is essential. Macrolide selection should consider local resistance and interactions. Antibiotics do not reverse established stenosis.
Diuretics require monitoring of weight, renal function, sodium and potassium. Beta-blockers, digoxin or selected calcium-channel blockers may be used for ventricular-rate control according to ventricular function, pregnancy and conduction status; avoid combining rate-slowing drugs without surveillance. Rheumatic mitral stenosis with atrial fibrillation requires vitamin K antagonist anticoagulation, with documented INR target, interaction counselling and a missed-dose or bleeding plan. Mechanical valves have prosthesis-specific INR requirements. Direct oral anticoagulants should not replace vitamin K antagonists for rheumatic mitral stenosis-associated atrial fibrillation or mechanical valves. ACE inhibitors, ARBs, ARNIs, mineralocorticoid antagonists and SGLT2 inhibitors may be relevant to concomitant systolic heart failure but do not open a stenotic valve and several are contraindicated in pregnancy. Infective-endocarditis prophylaxis is not routine for all native RHD; follow current high-risk criteria and emphasise oral health. Prescribing during pregnancy or lactation needs a Pregnancy Heart Team, especially anticoagulation for a mechanical valve.
When to Refer
Urgent hospital or tertiary referral is required for acute pulmonary oedema, hypoxaemia, low output, syncope with severe stenosis, rapid atrial fibrillation with instability, systemic embolism, suspected prosthetic-valve thrombosis, infective endocarditis, decompensation during pregnancy or severe pulmonary hypertension with right-heart failure. Possible ARF with carditis, neurological chorea that compromises safety, or diagnostic uncertainty also merits paediatric or medical specialist assessment. Do not wait for an elective echo slot when clinical physiology is deteriorating. Obtain blood cultures before antibiotics in suspected endocarditis when this does not delay resuscitation.
Planned valve-centre referral is indicated for symptomatic clinically severe mitral stenosis, severe regurgitation, progressive ventricular consequences, pulmonary hypertension, new atrial fibrillation, recurrent embolism, mixed or multivalve disease and declining exercise capacity. Anatomy and transoesophageal imaging determine suitability for percutaneous commissurotomy; surgery should be discussed before advanced right-heart or end-organ damage makes risk prohibitive. Every woman with moderate or severe valve disease needs pre-conception counselling. Significant mitral stenosis should be assessed for intervention before pregnancy where possible; a mechanical prosthesis requires an expert anticoagulation plan before conception. Refer children and adolescents into an ARF/RHD register with prophylaxis ownership, not only to a one-time cardiology visit. In India, link district hospital, DEIC or RBSK pathways, medical-college cardiology and public cardiac surgery according to local availability. Record whether the referral was reached and what financial or transport barrier remains.
Red Flags
Pink frothy sputum, severe orthopnoea, hypoxaemia, hypotension, cool peripheries, confusion or oliguria indicate pulmonary oedema or low-output failure. A very rapid or newly irregular pulse may be atrial fibrillation; focal weakness, aphasia or visual loss may be systemic embolism and requires a stroke pathway. Haemoptysis in mitral stenosis can reflect severe pulmonary venous hypertension but pulmonary embolism, infection and other causes remain possible. Syncope, exertional chest pressure or right-heart failure with severe pulmonary hypertension signals advanced haemodynamic compromise. Fever, rigors, a changing murmur, prosthetic-valve dysfunction or embolic signs raise infective endocarditis. Sudden dyspnoea in an anticoagulated mechanical-valve patient raises valve thrombosis until excluded.
During pregnancy, inability to lie flat, resting tachycardia, falling oxygen saturation, haemoptysis, syncope or rapid atrial fibrillation is not normal gestational discomfort. Severe mitral stenosis can deteriorate as plasma volume and heart rate rise, and the early postpartum fluid shift remains hazardous. During secondary prophylaxis, wheeze, urticaria, angioedema, hypotension or respiratory compromise after penicillin requires immediate anaphylaxis management; simple injection pain or a vasovagal episode should be documented accurately but never dismissed without assessment. A child with migratory arthritis, chorea, carditis, nodules or erythema after a compatible infection needs prompt ARF evaluation because early recognition can alter lifelong risk. Recurrent ARF despite reported prophylaxis should trigger verification of product, dose, interval, administration and adherence barriers rather than automatic escalation without a root-cause review.
Indian Clinical Context
India’s Ministry of Health and Family Welfare published a 2016 RHD manual for medical officers that envisaged integrating screening, diagnosis, referral, treatment and education through the NPCDCS and Rashtriya Bal Swasthya Karyakram platforms. That operational framework is not evidence that every district currently provides the complete pathway. RBSK can support school-age detection and referral, while district hospitals, District Early Intervention Centres, medical colleges and state cardiac programmes vary in echocardiography, benzathine penicillin supply, INR testing, commissurotomy and surgery. The safe local plan names the actual clinic, injection day, backup stock source, recall method, echo site and escalation centre rather than promising a nominal programme entitlement.
Benzathine penicillin continuity is a health-system quality measure. Registers should capture due and received dates, not just prescriptions. Community health workers, school teams and family education can address travel, fear and missed attendance; clinics need staff trained in injection technique and anaphylaxis response. Point-of-care INR or decentralised monitoring may reduce travel for warfarin where quality assurance exists. International WHO guidance supports prevention and screening strategies, and ESC guidance informs valve intervention and pregnancy, but neither guarantees Indian availability. Screening without confirmatory echo, prophylaxis supply and referral risks creating diagnosis without care. Genetics research may illuminate susceptibility, yet no genetic screening replaces sore-throat treatment or secondary prophylaxis. Financial counselling should explore Ayushman Bharat and state schemes without promising eligibility. Women and adolescents need proactive reproductive counselling because an emergency pregnancy referral is much less safe than planned assessment and, where indicated, valve intervention before conception.
NMC Competency Mapping
RHD connects paediatrics, medicine, community medicine, microbiology, pharmacology and obstetrics. A learner should recognise manifestations of ARF, use Jones criteria with evidence of preceding streptococcal infection, and understand the role and limitations of inflammatory markers and antibody titres. Cardiovascular skills include identifying mitral stenosis and regurgitation signs, assessing atrial fibrillation, congestion, pulmonary hypertension and low output, and interpreting ECG, chest radiography and an echocardiographic summary. The student should distinguish acute fever prevention, secondary recurrence prevention and treatment of established valve consequences.
Applied prescribing competence includes selecting and safely delivering secondary penicillin prophylaxis, eliciting a genuine allergy history, recognising anaphylaxis, arranging the next dose and explaining why adherence is long term. Learners should know when anticoagulation is indicated in rheumatic mitral stenosis, why a vitamin K antagonist remains necessary, how INR monitoring affects safety, and why diuretics do not correct mechanical obstruction. Referral competence includes pulmonary oedema, embolic stroke, endocarditis, severe stenosis, pulmonary hypertension and pregnancy risk. Community-medicine learning should examine crowding, access, school health, registers, supply continuity and the limited geographic evidence for Indian pilot programmes rather than claiming universal coverage. Advanced valve quantification, commissurotomy selection, surgery, prosthesis choice and pregnancy anticoagulation remain supervised specialist competencies. Departments should map these outcomes to the current NMC documents and local resources instead of fabricating a single RHD competency code.
Key Exam Pearls for NEET PG
ARF is an immune sequela of group A streptococcal infection; chronic RHD is the structural valve consequence. Mitral regurgitation often predominates during acute carditis, whereas commissural fusion and subvalvular scarring later produce the classic stenotic valve. Echocardiography detects clinical and subclinical carditis and defines stenosis by valve area, gradient and consequences. Antistreptolysin O supports preceding infection in the right context but does not diagnose RHD. Atrial fibrillation, a large left atrium, spontaneous echo contrast and prior embolism increase thromboembolic concern. In rheumatic mitral stenosis with atrial fibrillation, use a vitamin K antagonist rather than a direct oral anticoagulant.
Secondary prophylaxis prevents recurrent ARF and further valve damage; intramuscular benzathine penicillin is generally preferred, and duration extends with residual disease, exposure risk and valve intervention history. Surgery does not automatically end prophylaxis. Diuretics relieve congestion but do not alter valve area. Percutaneous mitral commissurotomy is suited to clinically severe rheumatic stenosis with favourable morphology and no left-atrial thrombus or more than mild regurgitation; otherwise surgery may be required. Significant mitral stenosis is poorly tolerated in pregnancy because tachycardia and increased blood volume raise the transmitral gradient. Pre-conception evaluation and, when indicated, intervention are safer than waiting for decompensation. Native RHD alone is not a blanket indication for dental endocarditis prophylaxis. Familial clustering does not create a clinically validated genetic test: prevention, echo assessment and family awareness remain the practical tools.
Frequently Asked Questions
Does valve surgery or balloon commissurotomy mean secondary penicillin prophylaxis can stop?
No. An intervention treats the haemodynamic valve lesion but does not remove susceptibility to recurrent acute rheumatic fever or protect remaining native valve tissue. Duration depends on prior fever, residual disease, age and exposure risk and may be very prolonged or lifelong. A cardiology or ARF programme should document the plan explicitly.
Can a positive antistreptolysin O titre diagnose rheumatic heart disease by itself?
No. The titre is evidence of a preceding immune response to streptococcal infection and varies with timing and background exposure. ARF diagnosis uses a compatible clinical syndrome and Jones criteria, while chronic RHD requires characteristic structural valve findings, usually on echocardiography. An isolated titre should not trigger a lifelong label.
Why are direct oral anticoagulants avoided in atrial fibrillation with rheumatic mitral stenosis?
Randomised evidence and current valve guidance support vitamin K antagonist therapy for atrial fibrillation associated with rheumatic mitral stenosis. Direct oral anticoagulants should not be substituted simply to avoid INR monitoring. The prescription needs an individual target, interaction and bleeding plan, reliable INR access and pregnancy review.
Can a person with rheumatic mitral stenosis plan a pregnancy safely?
Risk depends on valve area, symptoms, pulmonary pressure, rhythm, ventricular function and previous events. Significant stenosis can decompensate during pregnancy and postpartum. Assessment by a Pregnancy Heart Team before conception allows consideration of commissurotomy, medicine and anticoagulation changes, surveillance, delivery planning and contraception if pregnancy risk is currently unacceptable.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic